<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03684577</url>
  </required_header>
  <id_info>
    <org_study_id>WIKI-A</org_study_id>
    <nct_id>NCT03684577</nct_id>
  </id_info>
  <brief_title>Efficacy of Hypnotherapy for Agoraphobia</brief_title>
  <acronym>WIKI-A</acronym>
  <official_title>Efficacy of Hypnotherapy Compared to a Wait-list Control Group in the Treatment of Agoraphobia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to compare the efficacy of Hypnotherapy for the treatment of&#xD;
      Agoraphobia compared to a wait-list control group.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      With the present study, the efficacy of 8-12 sessions of individual Hypnotherapy will be&#xD;
      compared to a wait-list control groups. At study entry and at the end of treatment with&#xD;
      Hypnotherapy, the Agoraphobia symptoms will be assessed via clinician-rating and self-report.&#xD;
      It is expected that Hypnotherapy will be superior to a wait-list control regarding the&#xD;
      percentage reduction of the anxiety symptoms after three months of treatment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2018</start_date>
  <completion_date type="Actual">September 29, 2020</completion_date>
  <primary_completion_date type="Actual">June 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Panic and Agoraphobia Scale (PAS)</measure>
    <time_frame>Between baseline (t1) and after 12 weeks (t2)</time_frame>
    <description>The clinician-rating PAS will be used to measure the symptom severity (range 0-56 with higher values indicating more symptoms) for the primary outcome that is defined as the (mean) percentage change of the total symptom score between baseline (t1) and after 12 weeks (t2).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Agoraphobia</condition>
  <arm_group>
    <arm_group_label>Hypnotherapy for Agoraphobia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A total of 8-12 individual sessions of hypnotherapy over 12 weeks will be delivered. Hypnotherapy consists of hypnotic activation and reinforcement of the patient's own resources, the use of relevant positive and negative experiences from the biography, and the development of positive solution imagery. The central technique is the work with a symptom regression and the resolution of old and actual experiences. Furthermore, formal trance induction, utilisation techniques, indirect techniques such as the use of metaphors or the representative technique, or work with time progression will be used.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wait-list control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients in the wait-list control group will receive 8-12 sessions of individual hypnotherapy after a waiting period for 12 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Hypnotherapy for Agoraphobia</intervention_name>
    <description>see description of the experimental arm</description>
    <arm_group_label>Hypnotherapy for Agoraphobia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
          -  Patient fulfills DSM-5 (Diagnostic and Statistical Manual of Mental Disorders)&#xD;
             criteria for agoraphobia&#xD;
&#xD;
          -  18 - 65 years of age&#xD;
&#xD;
          -  Sufficient knowledge of the German language in order to participate in the study&#xD;
&#xD;
          -  Sufficient availability to participate in weekly therapy sessions&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Acute suicidality (intended action, concrete plans or intermittent pronounced suicidal&#xD;
             ideation)&#xD;
&#xD;
          -  Lifetime diagnosis of a bipolar disorder or psychotic disorder&#xD;
&#xD;
          -  Alcohol or substance use disorder without abstinence in the last 12 months&#xD;
&#xD;
          -  Severe cognitive impairments (in cases of suspicion evaluation via Mini Mental State&#xD;
             Test (MMST) &lt; 26, will be conducted)&#xD;
&#xD;
          -  Other severe primary mental disorders to be treated: severe Major Depressive Disorder,&#xD;
             severe personality disorder of borderline type with self-injury, severe combined&#xD;
             personality disorder, actual posttraumatic stress disorder, anorexia nervosa,&#xD;
             obsessive compulsive disorder&#xD;
&#xD;
          -  Somatic disorder impeding participation in regular psychotherapy sessions&#xD;
&#xD;
          -  Outpatient psychotherapy during the last twelve months.&#xD;
&#xD;
          -  Medication with anxiolytics or anti-psychotics (antidepressant medication is permitted&#xD;
             if stable since more than eight weeks and no planned changes during the duration of&#xD;
             therapy)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anil Batra, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Tuebingen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Prof. Dr. A. Batra/ Dr. Kristina Fuhr, University Department for Psychiatry and Psychotherapie</name>
      <address>
        <city>Tuebingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>September 21, 2018</study_first_submitted>
  <study_first_submitted_qc>September 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 25, 2018</study_first_posted>
  <last_update_submitted>November 3, 2020</last_update_submitted>
  <last_update_submitted_qc>November 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Tuebingen</investigator_affiliation>
    <investigator_full_name>Anil Batra</investigator_full_name>
    <investigator_title>Prof. Dr. Anil Batra, Pricinpal Investigator</investigator_title>
  </responsible_party>
  <keyword>Hypnosis</keyword>
  <keyword>Wait-list</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Agoraphobia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

